EFECT Trademark

Trademark Overview

On Friday, July 12, 2013, a trademark application was filed for EFECT with the United States Patent and Trademark Office. The USPTO has given the EFECT trademark a serial number of 86009229. The federal status of this trademark filing is REGISTERED as of Tuesday, June 2, 2020. This trademark is owned by Zymeworks Inc.. The EFECT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Therapeutic, prophylactic preparations, and pharmaceutical preparations and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases, namely, rheumatoid arthritis, Crohn's disease, multiple sclerosis, inflammatory connective tissue diseases, irritable bowel disease, irritable bowel syndrome, colitis, pelvic inflammatory disease, and scleroderma

Licensing of proprietary intellectual property

Scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases
efect

General Information

Serial Number86009229
Word MarkEFECT
Filing DateFriday, July 12, 2013
Status700 - REGISTERED
Status DateTuesday, June 2, 2020
Registration Number6066433
Registration DateTuesday, June 2, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 17, 2020

Trademark Statements

Goods and ServicesTherapeutic, prophylactic preparations, and pharmaceutical preparations and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases, namely, rheumatoid arthritis, Crohn's disease, multiple sclerosis, inflammatory connective tissue diseases, irritable bowel disease, irritable bowel syndrome, colitis, pelvic inflammatory disease, and scleroderma
Pseudo MarkEFFECT
Goods and ServicesLicensing of proprietary intellectual property
Goods and ServicesScientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 20, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 16, 2014
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZYMEWORKS BC INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressVANCOUVER V5T1G4
CA
Party NameZymeworks Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVancouver V5T1G4
CA
Party NameZymeworks Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBritish Columbia V6H3V9
CA
Party NameZymeworks Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBritish Columbia V6H3V9
CA

Trademark Events

Event DateEvent Description
Wednesday, December 14, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 21, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 2, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 24, 2020EXAMINER'S AMENDMENT ENTERED
Friday, January 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 24, 2020EXAMINERS AMENDMENT E-MAILED
Friday, January 24, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 21, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 21, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 21, 2020FINAL REFUSAL E-MAILED
Tuesday, January 21, 2020FINAL REFUSAL WRITTEN
Tuesday, December 31, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 30, 2019ASSIGNED TO LIE
Wednesday, December 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2019NON-FINAL ACTION WRITTEN
Monday, June 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 15, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, January 15, 2019INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 15, 2019SUSPENSION INQUIRY WRITTEN
Tuesday, January 15, 2019SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, June 28, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 28, 2018LETTER OF SUSPENSION E-MAILED
Thursday, June 28, 2018SUSPENSION LETTER WRITTEN
Wednesday, June 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 22, 2018ASSIGNED TO LIE
Monday, June 11, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 22, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 22, 2017INQUIRY TO SUSPENSION E-MAILED
Friday, December 22, 2017SUSPENSION INQUIRY WRITTEN
Tuesday, December 19, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Saturday, June 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, June 17, 2017LETTER OF SUSPENSION E-MAILED
Saturday, June 17, 2017SUSPENSION LETTER WRITTEN
Friday, June 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 2, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 19, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, December 19, 2016INQUIRY TO SUSPENSION E-MAILED
Monday, December 19, 2016SUSPENSION INQUIRY WRITTEN
Friday, December 16, 2016SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, June 16, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 16, 2016LETTER OF SUSPENSION E-MAILED
Thursday, June 16, 2016SUSPENSION LETTER WRITTEN
Tuesday, June 14, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 9, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 18, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 18, 2015INQUIRY TO SUSPENSION E-MAILED
Friday, December 18, 2015SUSPENSION INQUIRY WRITTEN
Tuesday, December 15, 2015SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Sunday, June 14, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, June 14, 2015LETTER OF SUSPENSION E-MAILED
Sunday, June 14, 2015SUSPENSION LETTER WRITTEN
Thursday, May 28, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 28, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 22, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 26, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, November 26, 2014INQUIRY TO SUSPENSION E-MAILED
Wednesday, November 26, 2014SUSPENSION INQUIRY WRITTEN
Wednesday, November 19, 2014SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, May 16, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 16, 2014LETTER OF SUSPENSION E-MAILED
Friday, May 16, 2014SUSPENSION LETTER WRITTEN
Friday, May 16, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 16, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 7, 2014ASSIGNED TO LIE
Tuesday, April 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 29, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2013NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2013NON-FINAL ACTION WRITTEN
Thursday, October 24, 2013ASSIGNED TO EXAMINER
Tuesday, July 23, 2013NOTICE OF PSEUDO MARK E-MAILED
Saturday, July 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 16, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

efect diseases inflammatory immune auto cancer disease preparations namely development scientific